VRSK

Verisk Analytics faces a mixed outlook with subscription revenues growing 8% and AI-driven XactAI reaching 7,000 licensees, but transactional revenues declined 4.2% due to sluggish insurance markets. Rising operating costs and uncertain AI monetization prospects weigh on profitability, resulting in a Hold rating.

Verisk Analytics (VRSK), a leading data analytics and technology provider to the insurance industry, is highlighted as a stock to watch. Despite holding a #3 (Hold) Zacks Rank, the company demonstrates strong growth prospects with a Grade A Growth Style Score and forecasted year-over-year earnings growth of 7.7%. Two analysts have raised earnings estimates in the last 60 days, and the company maintains a solid average earnings surprise of +5.3%.

Verisk Analytics (VRSK) has been upgraded to a Zacks Rank #2 (Buy) rating due to upward trends in earnings estimates. The company is positioned in the top 20% of Zacks-covered stocks based on earnings estimate revisions, suggesting potential for near-term stock price appreciation. Analysts have steadily raised estimates over the past three months with a 1.1% increase in the Zacks Consensus Estimate.

Verisk Analytics (VRSK) is expanding its insurance capabilities through AI, cloud platforms, and strategic acquisitions, with strong Q2 2026 cash flow growth of 49.7% in operating cash flow and 57.9% in free cash flow. However, the company faces headwinds from elevated debt levels ($4.47B), rising interest expenses ($52.8M in Q2), and increased personnel and legal costs that compressed GAAP net income by 9.8% and margins to 28.4%. The company maintains a Zacks Rank #3 (Hold) rating.

Verisk announced it will comply with the Delaware Supreme Court's affirmation of the Delaware Chancery Court's judgment regarding the AccuLynx transaction. The company stated the deal remains subject to customary closing conditions and FTC review with no guarantee of completion. Verisk reaffirmed its commitment to serving the global insurance industry.